Pertussis Therapeutic Market Size
Market Size in USD Bn
CAGR3.6%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 3.6% |
| Market Concentration | High |
| Major Players | Tianjin CanSino Biotechnology, ILiAD Biotechnologies, GlaxoSmithKline (GSK), Sanofi, AstraZeneca and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Pertussis Therapeutic Market Analysis
The pertussis therapeutic market is estimated to be valued at USD 3.94 Bn in 2025 and is expected to reach USD 5.05 Bn by 2032, growing at a compound annual growth rate (CAGR) of 3.6% from 2025 to 2032. The market has been witnessing steady growth over the past few years driven by high prevalence of pertussis across the globe.